Kiniksa Pharmaceuticals International, plc Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -65.07M-104.20M-166.01M-167.13M-165.67M267.43M-60.40M-43.19M
Depreciation and Depletion 0.03M0.29M2.07M2.40M1.46M1.18M1.11M0.45M
Share-based Compensation 0.90M5.70M15.08M20.88M25.17M25.12M27.15M30.69M
Deferred Taxes -0.20M-0.98M-3.16M4.36M0.01M-185.50M-33.79M8.13M
Gains from Sales and Divestitures 0.25M0.52M0.68M
Gains from Investment Securities 0.23M1.78M18.27M9.23M10.14M11.60M9.73M
Non-cash Items 4.73M32.63M54.65M7.68M
Cash from Operations -50.22M-81.01M-158.37M-136.53M-126.30M5.81M13.30M25.69M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.42M3.50M-0.12M-0.66M0.08M1.07M-0.44M
Depreciation & Amortization (CF) 0.03M0.29M2.07M2.40M2.35M2.40M2.34M1.70M
Change in Working Capital
Change in Receivables 3.91M8.68M8.61M20.46M
Change in Inventory 3.67M17.92M9.52M-4.76M
Change in Account Payables 1.01M8.82M-4.71M-4.97M1.37M6.03M0.35M-6.31M
Change in Accured Expenses 4.11M9.30M4.64M8.80M10.34M-3.71M16.94M43.73M
Other Working Capital Changes 1.19M4.79M-1.26M-1.70M-2.94M12.00M7.07M19.55M
Investing Activities
Capital Expenditures 0.07M5.29M3.20M0.28M0.41M0.10M0.13M0.28M
Sales of Property, Plant and Equipment 0.09M0.03M
Change in Intangibles 20.00M
Change in Acquisitions & Divestments 168.10M541.19M407.05M306.30M127.80M175.51M239.94M
Cash from Investing Activities -0.07M-239.20M49.21M-23.44M128.63M-8.08M-29.56M37.67M
Financing Activities
Other financing activities 3.66M0.12M1.14M
Cash from Financing Activities 39.87M346.74M84.11M227.09M5.88M2.52M1.50M12.27M
Additional items
Change in Cash -10.41M26.53M-25.05M67.11M8.22M0.24M-14.76M75.63M
Beginning Cash Balance 10.41M-26.53M25.05M-67.11M114.25M122.47M122.72M107.95M
Free Cash Flow -50.29M-86.30M-161.57M-136.81M-126.71M5.70M13.17M25.41M
Net Cash Flow -10.41M26.53M-25.05M67.11M8.22M0.24M-14.76M75.63M